SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FERRARI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 46.928
AS - Asia 20.634
EU - Europa 13.763
SA - Sud America 3.715
AF - Africa 337
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 22
AN - Antartide 2
Totale 85.458
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 46.197
SG - Singapore 8.580
CN - Cina 5.709
IT - Italia 3.719
BR - Brasile 3.117
UA - Ucraina 2.487
HK - Hong Kong 2.126
DE - Germania 2.066
TR - Turchia 1.529
GB - Regno Unito 1.363
VN - Vietnam 1.185
FI - Finlandia 809
SE - Svezia 771
RU - Federazione Russa 656
PL - Polonia 638
MX - Messico 367
FR - Francia 322
ID - Indonesia 306
CA - Canada 281
IN - India 269
AR - Argentina 227
NL - Olanda 167
BD - Bangladesh 162
JP - Giappone 143
ZA - Sudafrica 138
ES - Italia 131
BE - Belgio 119
IQ - Iraq 115
EC - Ecuador 112
AT - Austria 102
CO - Colombia 73
LT - Lituania 65
PK - Pakistan 65
CZ - Repubblica Ceca 63
VE - Venezuela 52
IE - Irlanda 47
CH - Svizzera 45
EG - Egitto 45
KR - Corea 43
UZ - Uzbekistan 43
CL - Cile 42
AU - Australia 41
PY - Paraguay 41
MA - Marocco 34
JO - Giordania 28
AE - Emirati Arabi Uniti 25
KE - Kenya 25
TN - Tunisia 25
IR - Iran 24
SA - Arabia Saudita 24
PE - Perù 23
TW - Taiwan 23
LK - Sri Lanka 21
UY - Uruguay 21
AL - Albania 20
MY - Malesia 20
GE - Georgia 19
IL - Israele 19
BG - Bulgaria 18
RO - Romania 17
DZ - Algeria 16
NZ - Nuova Zelanda 15
RS - Serbia 15
HR - Croazia 14
JM - Giamaica 14
PH - Filippine 14
SN - Senegal 14
TH - Thailandia 14
AZ - Azerbaigian 13
KZ - Kazakistan 13
OM - Oman 13
PT - Portogallo 13
EU - Europa 12
GR - Grecia 12
HU - Ungheria 11
LB - Libano 11
NO - Norvegia 11
TT - Trinidad e Tobago 11
KG - Kirghizistan 10
PS - Palestinian Territory 10
PA - Panama 9
BH - Bahrain 8
DK - Danimarca 8
GT - Guatemala 8
NP - Nepal 8
XK - ???statistics.table.value.countryCode.XK??? 8
BA - Bosnia-Erzegovina 7
BY - Bielorussia 7
CI - Costa d'Avorio 7
MD - Moldavia 7
NI - Nicaragua 7
SK - Slovacchia (Repubblica Slovacca) 7
DO - Repubblica Dominicana 6
ET - Etiopia 6
HN - Honduras 6
SI - Slovenia 6
SV - El Salvador 6
AM - Armenia 5
BN - Brunei Darussalam 5
CR - Costa Rica 5
Totale 85.356
Salva come PNG Salva come JPEG
Città #
Fairfield 5.337
Woodbridge 5.001
Singapore 4.796
Ashburn 4.295
Houston 3.186
Jacksonville 2.708
Chandler 2.389
Seattle 2.122
Hong Kong 2.108
Ann Arbor 2.106
Wilmington 1.878
Cambridge 1.776
Santa Clara 1.679
Dallas 1.645
Beijing 1.627
Izmir 955
Nanjing 871
Princeton 751
Warsaw 602
Los Angeles 542
New York 484
San Diego 477
Munich 431
Boardman 425
Ferrara 405
Ho Chi Minh City 402
Milan 372
São Paulo 292
Shanghai 270
Shenyang 262
Mexico City 253
Nanchang 245
Hanoi 228
Jakarta 228
Moscow 218
Chicago 181
Rome 180
London 179
Hefei 169
Tianjin 163
Helsinki 159
Falls Church 155
Changsha 154
Hebei 147
Jiaxing 147
Turku 139
Bremen 134
Redwood City 132
Tokyo 124
San Mateo 121
Mountain View 119
Dong Ket 118
Brussels 111
Rio de Janeiro 110
Addison 107
Brooklyn 107
The Dalles 104
Buffalo 102
Jinan 101
Bologna 95
Zhengzhou 93
Nuremberg 84
Montreal 82
Norwalk 82
Dearborn 80
Chennai 79
Phoenix 78
Johannesburg 77
Stockholm 76
Falkenstein 75
Orem 72
Naples 71
San Francisco 70
Council Bluffs 69
San Jose 69
Columbus 68
Boston 67
Denver 65
Ningbo 65
Belo Horizonte 64
Guangzhou 64
Verona 63
Kunming 62
Washington 62
Atlanta 61
Toronto 60
Manchester 59
Des Moines 53
Poplar 53
Philadelphia 52
Curitiba 51
Frankfurt am Main 51
Orange 51
Brasília 50
Taizhou 48
Haiphong 45
Ankara 44
Napoli 43
Quito 43
Mumbai 41
Totale 57.266
Salva come PNG Salva come JPEG
Nome #
IL METABOLISMO DEL MIOCARDIO ISCHEMICO IBERNATO E STORDITO: DIFFERENZA TRA NECROSI E APOPTOSI 1.805
1,3,8-Triazaspiro compounds and their use as medicaments for the treatment of reperfusion injury. 1.038
Il lungo cammino degli inibitori dell'enzima di conversione dell'angiotensina nella lotta per le malattie cardiovascolari 434
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 397
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 379
Valutazione ecocardiografica dell'insufficienza mitralica nella prospettiva della riparazione valvolare 344
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 338
Left ventricular ejection fraction and heart failure: an indissoluble marriage? 338
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 327
The Notch pathway: a novel therapeutic target for cardiovascular diseases? 309
Scompenso cardiaco con frazione di eiezione intermedia. Alla ricerca della Terra di Mezzo? 307
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 301
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy 270
Distinct gene expression profiles associated with Notch ligands Delta-like 4 and Jagged1 in plaque material from peripheral artery disease patients: A pilot study 267
Estrogen receptor β-dependent Notch1 activation protects vascular endothelium against tumor necrosis factor α (TNFα)-induced apoptosis 263
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 252
Polar plot maps by parametric strain echocardiography allow accurate evaluation of non-viable transmural scar tissue in ischaemic heart disease 245
Demographic and clinical characteristics of patients with stable coronary artery disease: results from the CLARIFY registry in Spain 242
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) 241
2014 ESC guidelines on the diagnosis and treatment of aortic diseases 238
17β-Estradiol Enhances Signalling Mediated by VEGF-A-Delta-Like Ligand 4-Notch1 Axis in Human Endothelial Cells 236
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 234
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 233
Cardiac resynchronization therapy guided by multimodality cardiac imaging 232
CANCER THERAPY-INDUCED CARDIOTOXICITY: ROLE OF ULTRASOUND DEFORMATION IMAGING AS AN AID TO EARLY DIAGNOSIS 231
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 231
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 229
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 226
Poor response to clopidogrel: current and future options for its management 225
The role of Notch pathway in cardiovascular diseases. 222
2013 ESC guidelines on the management of stable coronary artery disease 218
2013 ESH/ESC Guidelines for the management of arterial hypertension 218
New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma 215
Reversibility of Left Ventricle Longitudinal Strain Alterations Induced by Adjuvant Therapy in Early Breast Cancer Patients 215
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 214
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 210
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 210
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 208
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 207
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 206
null 206
KRIT1 deficiency promotes aortic endothelial dysfunction 204
A Clinical Case of Catecholaminergic Polymorphic Ventricular Tachycardia: The Clinical Suspicious and the Need of Genetics 203
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 202
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 202
Abnormalities of Left Ventricular Function in Asymptomatic Patients with Systemic Sclerosis Using Doppler Measures of Myocardial Strain 201
Uric acid and coronary artery disease: An elusive link deserving further attention 200
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT) 199
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 197
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 197
Heart failure with preserved ejection fraction: uncertainties and dilemmas 194
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 194
Current views on anthracycline cardiotoxicity 194
Left Ventricular Lead Position Guided by Parametric Strain Echocardiography Improves Response to Cardiac Resynchronization Therapy 193
Attualità e nuove prospettive in tema di cardiogenetica 191
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 190
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals 190
Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion 189
181 QUESTIONS & ANSWERS IN HEART FAILURE Heart failure 181 Questions & Answers. 189
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL 187
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 187
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 186
Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome 186
Can we improve myocardial protection during ischaemic injury? 186
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 185
Aortic valve stenosis and mitochondrial dysfunctions: Clinical and molecular perspectives 185
Angina and left ventricular dysfunction: can we "reduce' it? 184
The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors 183
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 182
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 181
Current role of echocardiography in cardiac resynchronization therapy 179
Anti-anginal drugs: Systematic review and clinical implications 179
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 178
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 177
Remote monitoring of implantable devices: Should we continue to ignore it? 176
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 176
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 176
2013 ESCGuidelines on cardiac pacing and cardiac resynchronization therapy 175
Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress 175
Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction 174
The in vitro effects of verbascoside on human platelet aggregation 174
Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: An analysis from the SIGNIFY study 174
Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: Analysis of the CLARIFY registry 174
Cardiovascular complications of radiation therapy for thoracic malignancies: The role for non-invasive imaging for detection of cardiovascular disease 174
Improved recognition of dysfunctioning myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction 172
99mTc-sestamibi gted -Spect evaluation of post stress left ventricular ejection fraction and volumes in hypertensive patients exhibiting a normal scintigraphic perfusion pattern 172
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 172
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 171
Prolonged propionyl-L-carnitine pre-treatment of rabbit: Biochemical, hemodynamic and electrophysiological effects on myocardium 171
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 171
Reperfusion Damage - A Story of Success, Failure, and Hope 171
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 171
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 170
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions 169
Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting 168
CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: systematic review and individual patient pooled meta-analysis 167
Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention 166
Impact of a recent hospitalization on treatment and prognosis of ST-segment elevation myocardial infarction 166
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients 166
Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach 166
Totale 23.692
Salva come PNG Salva come JPEG
Categoria #
all - tutte 412.386
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.783
Totale 418.169
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.143 0 0 0 0 0 913 316 1.061 254 1.119 996 484
2021/20227.070 323 777 577 273 413 357 359 366 296 505 753 2.071
2022/20236.078 715 190 226 668 982 900 219 634 840 60 397 247
2023/20243.481 359 433 210 120 238 490 152 206 77 160 153 883
2024/202512.621 303 307 1.107 466 1.429 1.036 462 840 2.357 1.378 1.541 1.395
2025/202620.092 3.125 1.753 4.140 4.575 4.716 1.783 0 0 0 0 0 0
Totale 86.447